Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Clin Cancer Res. 2014 Jan 14;20(5):1366–1374. doi: 10.1158/1078-0432.CCR-13-2442

Table 3.

Nonlinear mixed modeling: peak or nadir of inflammatory markers during the first 30 days post-AuSCT

Inflammatory marker Estimated peak or nadir (days from transplant) 95% CI P
Markers with significant peak
 IL-6 9.00 6.01 to 11.99 < 0.0001
 CRP 13.46 9.28 to 17.64 < 0.0001
 IL-10 18.01 13.43 to 22.59 < 0.0001
Markers with significant nadir
 SIL-1RA 4.71 1.69 to 7.72 0.003
 SIL-6R 8.16 5.40 to 10.93 < 0.0001
Markers with no significant peak or nadir
 IL-8 0 −47.1 to 47.1 0.999
 STNF-R1 1.01 −9.27 to 11.29 0.844
 STNF-R2 2.40 −2.56 to 7.37 0.335
 MCP-1 2.74 −0.04 to 5.52 0.054
 TNF-α 3.00 −1.54 to 7.54 0.191
 MIP-1α 6.00 0.54 to 11.46 0.032
 SIL-1R2 6.04 −4.55 to 16.62 0.257
 SIL-2RA 18.00 −38.31 to 74.31 0.524

Abbreviations: AuSCT, autologous hematopoietic stem cell transplant; CI, confidence interval.